Alan J Main

CIK 1227372 · EVP, Innov & Chem Sciences · last filed 2025-03-03

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Disclosed Exposure

$522.0K

Companies

Total Filings

Lifetime Open-Market Net

Charts

Trading activity, where the exposure sits, and each trade against the stock price.

LXRX price and trades

Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.

Shares held

Shares owned after each reported transaction on this company (direct holdings as reported).

Exposure by company

latest

OfficerDirector10% owner* stale (no filing in 3 yrs)

Most recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.

Symbol	Role	Shares	Price	Disclosed Exposure	Lifetime OM Net	Filings	Latest Filed
LXRX	EVP, Innov & Chem Sciences	281,391	$1.85	$522.0K	$0	36	2025-03-03
LEXICON PHARMACEUTICALS, INC. (LEXG) Delisted	EVP, Pharmaceutical Research	—	—	—	$0	1	2007-02-15

Recent Filings · Page 3 of 4

37 filings

Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.

Filed	Symbol	Action	Net Shares	Net $	Link
2016-02-16	LXRX	Grant (A)	—	$0	EDGAR
2015-03-03	LXRX	Mixed	+43,682	-$23.8K	EDGAR
2015-02-09	LXRX	Grant (A)	—	$0	EDGAR
2014-03-03	LXRX	Mixed	+31,582	-$35.8K	EDGAR
2014-02-10	LXRX	Grant (A)	—	$0	EDGAR
2013-03-01	LXRX	Mixed	+21,178	-$24.9K	EDGAR
2013-02-12	LXRX	Grant (A)	—	$0	EDGAR
2013-02-04	LXRX	Mixed	+19,063	-$26.5K	EDGAR
2012-03-01	LXRX	Mixed	+10,343	-$10.5K	EDGAR
2012-02-17	LXRX	Grant (A)	—	$0	EDGAR

Showing 21–30 of 37

Prev Page 3 of 4 Next

Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.